BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 35347026)

  • 21. Hypoxia-inducible factor-1alpha expression predicts a poor response to primary chemoendocrine therapy and disease-free survival in primary human breast cancer.
    Generali D; Berruti A; Brizzi MP; Campo L; Bonardi S; Wigfield S; Bersiga A; Allevi G; Milani M; Aguggini S; Gandolfi V; Dogliotti L; Bottini A; Harris AL; Fox SB
    Clin Cancer Res; 2006 Aug; 12(15):4562-8. PubMed ID: 16899602
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical value of significance of Hypoxia Inducible Factor-1α, Glucose Transporter-1 and Carbonic Anhydrase IX in rectal cancer after preoperative chemoradiotherapy.
    Vitoratou DI; Tolia M; Liakos P; Tsoukalas N; Giaginis C; Nikolaou M; Nikolaou G; Rigas G; Psarianos K; Lioupis A; Kyrgias G
    J BUON; 2019; 24(2):456-463. PubMed ID: 31127991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enrichment of CD133-expressing cells in rectal cancers treated with preoperative radiochemotherapy is an independent marker for metastasis and survival.
    Sprenger T; Conradi LC; Beissbarth T; Ermert H; Homayounfar K; Middel P; Rüschoff J; Wolff HA; Schüler P; Ghadimi BM; Rödel C; Becker H; Rödel F; Liersch T
    Cancer; 2013 Jan; 119(1):26-35. PubMed ID: 22736392
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical significance of radiation-induced CD133 expression in residual rectal cancer cells after chemoradiotherapy.
    Kawamoto A; Tanaka K; Saigusa S; Toiyama Y; Morimoto Y; Fujikawa H; Iwata T; Matsushita K; Yokoe T; Yasuda H; Inoue Y; Miki C; Kusunoki M
    Exp Ther Med; 2012 Mar; 3(3):403-409. PubMed ID: 22969903
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIF-1α Expression Increases Preoperative Concurrent Chemoradiotherapy Resistance in Hyperglycemic Rectal Cancer.
    Huang YJ; Chen YT; Huang CM; Kuo SH; Liao YY; Jhang WY; Wang SH; Ke CC; Huang YH; Cheng CM; Huang MY; Chuang CH
    Cancers (Basel); 2022 Aug; 14(16):. PubMed ID: 36011045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hypoxia, angiogenesis and apoptosis markers in locally advanced rectal cancer.
    Theodoropoulos GE; Lazaris AC; Theodoropoulos VE; Papatheodosiou K; Gazouli M; Bramis J; Patsouris E; Panoussopoulos D
    Int J Colorectal Dis; 2006 Apr; 21(3):248-57. PubMed ID: 16052307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of HIF-1alpha expression in patients with esophageal cancer treated with concurrent chemoradiotherapy.
    Ogawa K; Chiba I; Morioka T; Shimoji H; Tamaki W; Takamatsu R; Nishimaki T; Yoshimi N; Murayama S
    Anticancer Res; 2011 Jun; 31(6):2351-9. PubMed ID: 21737664
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical significance of immunohistochemical expression of hypoxia-inducible factor-1alpha as a prognostic marker in rectal adenocarcinoma.
    Lu XG; Xing CG; Feng YZ; Chen J; Deng C
    Clin Colorectal Cancer; 2006 Jan; 5(5):350-3. PubMed ID: 16512994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognostic Significance of Survivin Expression and Combined Analysis with Cancer Stem Cell and Epithelial-Mesenchymal Transition-related Markers in Patients with Rectal Cancer Undergoing Preoperative Chemoradiotherapy.
    Kim J; Ahn S; Kim K; Cho MS; Kim KH; Lee RA; Nam EM
    Anticancer Res; 2018 Dec; 38(12):6881-6889. PubMed ID: 30504405
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing to achieve the best recurrence-free survival after neoadjuvant chemoradiotherapy in locally advanced rectal cancer: experience in a large-volume center in China.
    Wang X; Zheng Z; Zhu H; Yu Q; Huang S; Lu X; Huang Y; Chi P
    Int J Colorectal Dis; 2021 May; 36(5):1007-1016. PubMed ID: 33398511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of pre- to post-chemoradiotherapy s-CEA reduction ratio in rectal cancer patients treated with preoperative chemoradiotherapy and curative resection.
    Kim CW; Yu CS; Yang SS; Kim KH; Yoon YS; Yoon SN; Lim SB; Kim JC
    Ann Surg Oncol; 2011 Nov; 18(12):3271-7. PubMed ID: 21537868
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Feasibility of Assessing Prognostic Nutrition Index in Patients With Rectal Cancer Who Receive Preoperative Chemoradiotherapy.
    Okugawa Y; Toiyama Y; Oki S; Ide S; Yamamoto A; Ichikawa T; Kitajima T; Fujikawa H; Yasuda H; Saigusa S; Hiro J; Yoshiyama S; Kobayashi M; Araki T; Kusunoki M
    JPEN J Parenter Enteral Nutr; 2018 Aug; 42(6):998-1007. PubMed ID: 29786882
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overexpression of hypoxia inducible factor-1 alpha is an independent risk factor for recurrence after curative resection of colorectal liver metastases.
    Shimomura M; Hinoi T; Kuroda S; Adachi T; Kawaguchi Y; Sasada T; Takakura Y; Egi H; Okajima M; Tashiro H; Nishizaka T; Ohdan H
    Ann Surg Oncol; 2013 Dec; 20 Suppl 3():S527-36. PubMed ID: 23748663
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD133 expression in renal cell carcinoma (RCC) is correlated with nuclear hypoxia-inducing factor 1α (HIF-1α).
    Sun C; Song H; Zhang H; Hou C; Zhai T; Huang L; Zhang L
    J Cancer Res Clin Oncol; 2012 Oct; 138(10):1619-24. PubMed ID: 22614155
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single nucleotide polymorphisms in the HIF-1α gene and chemoradiotherapy of locally advanced rectal cancer.
    Havelund BM; Spindler KL; Ploen J; Andersen RF; Jakobsen A
    Oncol Lett; 2012 Nov; 4(5):1056-1060. PubMed ID: 23162650
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Selective lateral pelvic lymph node dissection in patients with advanced low rectal cancer treated with preoperative chemoradiotherapy based on pretreatment imaging.
    Akiyoshi T; Ueno M; Matsueda K; Konishi T; Fujimoto Y; Nagayama S; Fukunaga Y; Unno T; Kano A; Kuroyanagi H; Oya M; Yamaguchi T; Watanabe T; Muto T
    Ann Surg Oncol; 2014 Jan; 21(1):189-96. PubMed ID: 23963871
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [18F]fluoro-2-deoxyglucose-positron emission tomography for the assessment of histopathological response after preoperative chemoradiotherapy in advanced oral squamous cell carcinoma.
    Shimomura H; Sasahira T; Yamanaka Y; Kurihara M; Imai Y; Tamaki S; Yamakawa N; Shirone N; Hasegawa M; Kuniyasu H; Kirita T
    Int J Clin Oncol; 2015 Apr; 20(2):308-16. PubMed ID: 24942501
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overexpression of hypoxia-inducible factor HIF-1alpha predicts early relapse in breast cancer: retrospective study in a series of 745 patients.
    Dales JP; Garcia S; Meunier-Carpentier S; Andrac-Meyer L; Haddad O; Lavaut MN; Allasia C; Bonnier P; Charpin C
    Int J Cancer; 2005 Sep; 116(5):734-9. PubMed ID: 15849727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical influence of cancer stem cells on residual disease after preoperative chemoradiotherapy for rectal cancer.
    Yoon G; Kim SM; Kim HJ; Seo AN
    Tumour Biol; 2016 Mar; 37(3):3571-80. PubMed ID: 26456957
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hypoxia-inducible factor 1 promotes chemoresistance of lung cancer by inducing carbonic anhydrase IX expression.
    Sowa T; Menju T; Chen-Yoshikawa TF; Takahashi K; Nishikawa S; Nakanishi T; Shikuma K; Motoyama H; Hijiya K; Aoyama A; Sato T; Sonobe M; Harada H; Date H
    Cancer Med; 2017 Jan; 6(1):288-297. PubMed ID: 28028936
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.